Status:
COMPLETED
Cognitive Behavioral Therapy and Light Therapy
Lead Sponsor:
University of Pennsylvania
Conditions:
Pulmonary Hypertension
Insomnia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cognitive behavioral therapy (CBT-I) is a common treatment for insomnia that does not use medications. While CBT-I is effective for insomnia, it does not tend to improve the waking symptom of fatigue....
Detailed Description
In a single site, 3-arm (Cognitive Behavioral Therapy \[CBT-I\] group; Bright Light Therapy group; Standard of Care group), parallel, randomized controlled trial we will enroll 36 subjects (n=12 per g...
Eligibility Criteria
Inclusion
- PAH diagnosis
- Insomnia
- Fatigue
Exclusion
- Untreated obstructive sleep apnea
- Subjects with left-sided valvular disease
- Hospitalized or acutely ill
- Any eye disease such as, but not limited to, cataracts, glaucoma, retinal disorders (e.g. macular degeneration), or previous eye surgery
- Subjects with photosensitivity (e.g. epilepsy)
- Manic-depressive psychosis or Bipolar Disorder
Key Trial Info
Start Date :
January 12 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2024
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT05337943
Start Date
January 12 2023
End Date
May 31 2024
Last Update
January 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104-4217